US Patent Issued to OBSIDIAN THERAPEUTICS on May 19 for "CA2 compositions and methods for tunable regulation" (Massachusetts Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,599, issued on May 19, was assigned to OBSIDIAN THERAPEUTICS INC. (Cambridge, Mass.).

"CA2 compositions and methods for tunable regulation" was invented by Michelle Lynn Ols (Cambridge, Mass.), Vipin Suri (Belmont, Mass.), Dexue Sun (Cambridge, Mass.), Dhruv Kam Sethi (Westwood, Mass.), Michael Schebesta (Cambridge, Mass.), Michelle Lois Fleury (Cambridge, Mass.) and Kutlu Goksu Elpek (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities." ...